KPJ HEALTHCARE BHD
KLSE (MYR): KPJ (5878)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
1.15
Today's Change
-0.02 (1.71%)
Day's Change
1.14 - 1.17
Trading Volume
14,153,400
Financial
Market Cap
Market Cap
5,206 Million
NOSH
4,527 Million
Latest Quarter
Latest Quarter
30-Jun-2023 [#2]
Announcement Date
29-Aug-2023
Next Quarter
30-Sep-2023
Est. Ann. Date
23-Nov-2023
Est. Ann. Due Date
29-Nov-2023
QoQ | YoY
-9.53% | 73.24%
T4Q Result
Revenue | NP to SH
3,218,590.000 | 225,210.000
RPS | P/RPS
71.10 Cent | 1.62
EPS | P/E | EY
4.98 Cent | 23.11 | 4.33%
DPS | DY | Payout %
2.69 Cent | 2.34% | 54.08%
NAPS | P/NAPS
0.49 | 2.34
QoQ | YoY
9.66% | 180.16%
NP Margin | ROE
7.51% | 10.13%
F.Y. | Ann. Date
30-Jun-2023 | 29-Aug-2023
Latest Audited Result
Latest Audited Result
31-Dec-2022
Announcement Date
27-Apr-2023
Next Audited Result
31-Dec-2023
Est. Ann. Date
27-Apr-2024
Est. Ann. Due Date
28-Jun-2024
Annual (Unaudited)
Revenue | NP to SH
2,920,658.000 | 171,992.000
RPS | P/RPS
64.52 Cent | 1.78
EPS | P/E | EY
3.80 Cent | 30.27 | 3.30%
DPS | DY | Payout %
1.92 Cent | 1.67% | 50.48%
NAPS | P/NAPS
0.47 | 2.45
YoY
237.02%
NP Margin | ROE
6.52% | 8.09%
F.Y. | Ann. Date
31-Dec-2022 | 17-Feb-2023
Annualized Result
Revenue | NP to SH
3,256,986.000 | 197,684.000
RPS | P/RPS
71.95 Cent | 1.60
EPS | P/E | EY
4.37 Cent | 26.33 | 3.80%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
-4.77% | 100.54%
NP Margin | ROE
6.44% | 8.89%
F.Y. | Ann. Date
30-Jun-2023 | 29-Aug-2023
Business Process
| Trailing 4 Quarters | Trailing 8 Quarters | |||
|---|---|---|---|---|
| Available Quarters | 4 Quarters | 8 Quarters | ||
| Continuous Quarters Of Revenue Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Total Positive Profit Years | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
| Continuous Quarters Of Positive Profit | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
| Continuous Quarters Of Profit Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Continuous Quarters Of Adjusted EPS Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Total Dividend Years | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
| Continuous Quarters Of Dividend | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
| Continuous Quarters Of Dividend Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
| Continuous Quarters Of Adjusted Dps Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
| Average ROE | 2.61% | 1.79% | ||
| Average Net Profit Margin | 7.52% | 5.55% | ||
| Last 5 Financial Years | Last 10 Financial Years | |||
|---|---|---|---|---|
| Available Years | 5 Years | 10 Years | ||
| Continuous Quarters Of Revenue Growth | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
| Total Positive Profit Years | 5 / 5 | 100.00% | 10 / 10 | 100.00% |
| Continuous Quarters Of Positive Profit | 5 / 5 | 100.00% | 10 / 10 | 100.00% |
| Continuous Quarters Of Profit Growth | 1 / 5 | 20.00% | 1 / 10 | 10.00% |
| Continuous Quarters Of Adjusted EPS Growth | 1 / 5 | 20.00% | 1 / 10 | 10.00% |
| Total Dividend Years | 5 / 5 | 100.00% | 10 / 10 | 100.00% |
| Continuous Quarters Of Dividend | 5 / 5 | 100.00% | 10 / 10 | 100.00% |
| Continuous Quarters Of Dividend Growth | 1 / 5 | 20.00% | 1 / 10 | 10.00% |
| Continuous Quarters Of Adjusted Dps Growth | 1 / 5 | 20.00% | 1 / 10 | 10.00% |
| Average ROE | 7.37% | 12.00% | ||
| Average Net Profit Margin | 5.11% | 5.19% | ||
Key Result
| T4Q | Annualized | Annual (Unaudited) | Last 10 FY Average | Last 5 FY Average | |
|---|---|---|---|---|---|
| Revenue | 3,218,590 | 3,256,986 | 2,920,658 | 2,879,628 | 2,971,486 |
| NP to SH | 225,210 | 197,684 | 171,992 | 142,222 | 144,856 |
| Dividend | 121,804 | 109,025 | 86,828 | 76,380 | 66,862 |
| Adjusted EPS | 4.98 | 4.37 | 3.80 | 3.14 | 3.20 |
| Adjusted DPS | 2.69 | 2.41 | 1.92 | 1.69 | 1.48 |
NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share
All figures in '000 unless specified.
EPS & DPS's figures in Cent.
Growth
| LQ QoQ | LQ YoY | CQ YoY | LQ vs Average of T4Q | LQ vs Average of T8Q | |
|---|---|---|---|---|---|
| Revenue | -3.55% | 12.99% | 19.87% | -0.64% | 7.22% |
| NP to Owner | -9.53% | 73.24% | 100.54% | -16.62% | 22.90% |
| Dividend | 8.33% | 161.17% | 179.03% | -6.91% | 37.49% |
| Adjusted EPS | -9.53% | 73.24% | 100.54% | -16.62% | 22.90% |
| Adjusted DPS | 8.33% | 161.17% | 179.03% | -6.91% | 37.49% |
LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year
| T4Q vs LFY | T4Q vs AL5FY | T4Q vs AL10FY | AQR vs LFY | AQR vs AL5FY | AQR vs AL10FY | LFY YoY | LFY vs AL5FY | LFY vs AL10FY | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.20% | 8.32% | 11.77% | 11.52% | 9.61% | 13.10% | 11.18% | -1.71% | 1.42% |
| NP to Owner | 30.94% | 55.47% | 58.35% | 14.94% | 36.47% | 39.00% | 237.02% | 18.73% | 20.93% |
| Dividend | 40.28% | 82.17% | 59.47% | 25.56% | 63.06% | 42.74% | 267.82% | 29.86% | 13.68% |
| Adjusted EPS | 30.94% | 55.47% | 58.35% | 14.94% | 36.47% | 39.00% | 237.02% | 18.73% | 20.93% |
| Adjusted DPS | 40.28% | 82.17% | 59.47% | 25.56% | 63.06% | 42.74% | 267.82% | 29.86% | 13.68% |
T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year
Discussions
4 people like this. Showing 50 of 1,819 comments
Through my own experience, never trust a doctor 100%, because they are human too.
Avoid abusing our own health is the best medicine and prevention from falling sick.
2023-01-01 13:52
Government hospitals now lack manpower and good service. Private hospitals like this one, with a huge private sector base (this being on panels of most multinationals and GLCs), should do well by default.
2023-02-08 09:33
First target for me is RM1.145, if hit, means can go higher after retrace.
2023-02-16 11:17
KPJ Healthcare reports over 3-fold profit jump in 4Q
https://www.thestar.com.my/business/business-news/2023/02/17/kpj-healthcare-reports-over-3-fold-profit-jump-in-4q
2023-02-17 22:00
Reiterate Add with a 12% higher TP of RM1.32
We raise FY23F/24F core EPS by 18%/16% to factor in lower opex and other
housekeeping adjustments post-FY22 results. Following our earnings upgrade, we raise
KPJ’s TP by 12% to RM1.32, based on an updated CY24F P/E of 31x (10-year mean, vs.
32x previously). While share price rose 34% from its 1-year low at end-Sep 22, its FY23F
P/E of 26.2x is still 17% (0.5 s.d.) below its 10-year historical mean. Potential re-rating
catalysts: full earnings recovery, rising health tourism contributions and improving ROIC.
Key downside risks: severe Covid-19 waves and longer gestation for its new hospitals.
CgsCimb 18/2/2023
2023-02-20 06:42
Institutional buying mostly, buyers' market. TP1.25 should be in hand within next week, quickest this week
2023-02-20 15:07
When qr out, a lot of people buy and somehow there are people press down the price, why? There must be something fishy
2023-02-23 14:08
Nothing fishy la, its normal for investors and traders to take profit after such a big run. It also means you get a chance to buy or add more.
2023-02-23 14:29
keep price low to buy up all the shares. that's JCorps plan via a GO later. looooong term hold
2023-02-27 00:09
JCORP is not buying KPJ shares.If it does it has to announce to Bursa.
2023-02-27 15:44
@Thankcarefully is right, but unfortunately people love to trade on rumour rather than facts. Anyway need to thank these people for selling low then buying back at high price.
2023-02-27 16:53
Q1 is always supossed to b lower bz in healthcare. dont b surprised this time is different.
2023-05-21 00:12
Buy Alaqar better. 2¢ dividend every 3 months. Alaqar owns all the hospitals assets of KPJ
2023-05-21 08:12
alaqar is great for passive investors. steady DV but growth capped. still a buy for long term passive holders.
2023-05-21 11:57
with better results end of may, kpj will be rerated higher by most analyst. expect a 10 to 15% rerating higher.
2023-05-21 11:58
If it stays above 1.14 with large volume, good possibility of testing 1.18 as first TP and 1.21 second TP
2023-06-14 10:42
results were consistant. epf have stopped selling and price will shoot up soon.
2023-06-19 01:16
Chairman at ystd AGM said he wasn't aware of any pte equity to buy a stake in KPJ. How can he be not aware of as it was in the news and vol of shares has been historical. Such a sweeping statement did not sound very professional.
2023-06-23 09:58
slow and steady yet solid profitability. I expect a sustained momentum for FY23. Keep it. 1.25 has yet to come..... maybe Novemberlah...
1 month ago
Post a Comment
Featured Posts
[04 OCT] 简单易懂的方式看懂图表分析
Trade Confidently & Analyze Charts Conveniently - Download VCPlus IOS & Android App Now!
Experience the All New Redesigned I3investor Mobile App. Available now.
MQ Trading Signals
Time
Signal
Duration
Type
2023-09-29 10:01:04
EMA 5
Daily
SELL
2023-09-29 09:59:01
TURTLE SYSTEM 20
Hourly
SELL
2023-09-29 09:59:01
TURTLE SYSTEM 55
Hourly
SELL
2023-09-29 09:21:53
ADX
30 Mins
SELL
Apps
Top Articles
1
2
3
save malaysia!
4
5
BFM Podcast
6
BFM Podcast
7
8
BFM Podcast
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
DickyMe
Wrong question!
Any high quality doctors there?
Currently many are being doctors for the status and remuneration without knowing the work of a doctor.
2023-01-01 13:27